CLINICAL_TRIALS
trial_result
· 2021-06-21
Clinical Trial Update: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 trial evaluating escalating doses of SAN-300 in rheumatoid arthritis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-21